These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9236628)

  • 1. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
    Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
    Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
    Filippi M; Rovaris M; Capra R; Gasperini C; Yousry TA; Sormani MP; Prandini F; Horsfield MA; Martinelli V; Bastianello S; Kühne I; Pozzilli C; Comi G
    Brain; 1998 Oct; 121 ( Pt 10)():2011-20. PubMed ID: 9798753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis.
    Gasperini C; Paolillo A; Rovaris M; Yousry TA; Capra R; Bastianello S; Filippi M
    Magn Reson Imaging; 2000 Jul; 18(6):761-3. PubMed ID: 10930786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis.
    Yousry TA; Fesl G; Walther E; Voltz R; Filippi M
    J Neurol Sci; 1998 Jun; 158(2):221-5. PubMed ID: 9702695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.
    Filippi M; Capra R; Campi A; Colombo B; Prandini F; Marcianò N; Gasparotti R; Comi G
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):526-30. PubMed ID: 8778257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.
    Filippi M; Campi A; Martinelli V; Colombo B; Yousry T; Canal N; Scotti G; Comi G
    J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):540-4. PubMed ID: 8530944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.
    van Waesberghe JH; Castelijns JA; Roser W; Silver N; Yousry T; Lycklama à Nijeholt GJ; Adèr HJ; Uitdehaag BM; Radue EW; Polman CH; Kappos L; Miller DH; Barkhof F
    AJNR Am J Neuroradiol; 1997 Aug; 18(7):1279-85. PubMed ID: 9282855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis.
    Filippi M; Rovaris M; Gasperini C; Capra R; Bastianello S; Kuhne I; Yousry TA
    J Neuroimaging; 1998 Apr; 8(2):88-93. PubMed ID: 9557146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrast.
    Bastianello S; Gasperini C; Paolillo A; Giugni E; Ciccarelli O; Sormani MP; Horsfield MA; Rovaris M; Pozzilli C; Filippi M
    AJNR Am J Neuroradiol; 1998; 19(10):1863-7. PubMed ID: 9874538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis.
    Silver NC; Good CD; Sormani MP; MacManus DG; Thompson AJ; Filippi M; Miller DH
    J Neurol; 2001 Mar; 248(3):215-24. PubMed ID: 11355156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
    Filippi M; Yousry T; Campi A; Kandziora C; Colombo B; Voltz R; Martinelli V; Spuler S; Bressi S; Scotti G; Comi G
    Neurology; 1996 Feb; 46(2):379-84. PubMed ID: 8614498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose.
    Yousry I; Filippi M; Walther E; Gasperini C; Capra R; Yousry TA
    Magn Reson Imaging; 2000 Nov; 18(9):1183-6. PubMed ID: 11118774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving acute demyelinating lesion detection: which T1-weighted magnetic resonance acquisition is more sensitive to gadolinium enhancement?
    Amaral LLFD; Fragoso DC; Rocha AJD
    Arq Neuropsiquiatr; 2019 Jul; 77(7):485-492. PubMed ID: 31365640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoteridol in multiple sclerosis patients. A comparison of single and triple dose with immediate vs. delayed imaging.
    Wolansky LJ; Finden SG; Chang R; Conigliari M; Lee HJ; Shaderowsky PD; Cook SD
    Clin Imaging; 1998; 22(6):385-92. PubMed ID: 9876905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.
    Rovaris M; Mastronardo G; Prandini F; Bastianello S; Comi G; Filippi M
    J Neurol Sci; 1999 Apr; 164(2):148-52. PubMed ID: 10402026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
    Livshits I; Hussein S; Kennedy C; Weinstock-Guttman B; Hojnacki D; Zivadinov R
    Minerva Med; 2012 Apr; 103(2):97-102. PubMed ID: 22513514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
    Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
    Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
    AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Gd-enhancement in brain MR of multiple sclerosis: image subtraction with and without magnetization transfer.
    Sardanelli F; Losacco C; Iozzelli A; Renzetti P; Rosso E; Parodi RC; Bonetti M; Murialdo A
    Eur Radiol; 2002 Aug; 12(8):2077-82. PubMed ID: 12136326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.